PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVS vs. PG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVS and PG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

NVS vs. PG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and The Procter & Gamble Company (PG). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
-8.48%
2.11%
NVS
PG

Key characteristics

Sharpe Ratio

NVS:

0.13

PG:

1.24

Sortino Ratio

NVS:

0.29

PG:

1.77

Omega Ratio

NVS:

1.04

PG:

1.24

Calmar Ratio

NVS:

0.11

PG:

2.10

Martin Ratio

NVS:

0.32

PG:

7.16

Ulcer Index

NVS:

7.02%

PG:

2.60%

Daily Std Dev

NVS:

16.66%

PG:

14.98%

Max Drawdown

NVS:

-41.72%

PG:

-54.23%

Current Drawdown

NVS:

-19.95%

PG:

-5.85%

Fundamentals

Market Cap

NVS:

$198.38B

PG:

$401.13B

EPS

NVS:

$5.73

PG:

$5.80

PE Ratio

NVS:

17.29

PG:

29.37

PEG Ratio

NVS:

2.95

PG:

3.60

Total Revenue (TTM)

NVS:

$49.29B

PG:

$83.91B

Gross Profit (TTM)

NVS:

$36.69B

PG:

$43.14B

EBITDA (TTM)

NVS:

$19.76B

PG:

$22.14B

Returns By Period

In the year-to-date period, NVS achieves a -0.50% return, which is significantly lower than PG's 18.33% return. Over the past 10 years, NVS has underperformed PG with an annualized return of 5.99%, while PG has yielded a comparatively higher 9.26% annualized return.


NVS

YTD

-0.50%

1M

-6.29%

6M

-8.48%

1Y

3.43%

5Y*

5.91%

10Y*

5.99%

PG

YTD

18.33%

1M

-0.92%

6M

2.11%

1Y

20.49%

5Y*

8.86%

10Y*

9.26%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVS vs. PG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NVS, currently valued at 0.13, compared to the broader market-4.00-2.000.002.000.131.24
The chart of Sortino ratio for NVS, currently valued at 0.29, compared to the broader market-4.00-2.000.002.004.000.291.77
The chart of Omega ratio for NVS, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.24
The chart of Calmar ratio for NVS, currently valued at 0.11, compared to the broader market0.002.004.006.000.112.10
The chart of Martin ratio for NVS, currently valued at 0.32, compared to the broader market0.0010.0020.000.327.16
NVS
PG

The current NVS Sharpe Ratio is 0.13, which is lower than the PG Sharpe Ratio of 1.24. The chart below compares the historical Sharpe Ratios of NVS and PG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.13
1.24
NVS
PG

Dividends

NVS vs. PG - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.90%, more than PG's 2.34% yield.


TTM20232022202120202019201820172016201520142013
NVS
Novartis AG
3.90%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%3.37%
PG
The Procter & Gamble Company
2.34%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.32%2.78%2.91%

Drawdowns

NVS vs. PG - Drawdown Comparison

The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum PG drawdown of -54.23%. Use the drawdown chart below to compare losses from any high point for NVS and PG. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-19.95%
-5.85%
NVS
PG

Volatility

NVS vs. PG - Volatility Comparison

Novartis AG (NVS) and The Procter & Gamble Company (PG) have volatilities of 4.69% and 4.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%JulyAugustSeptemberOctoberNovemberDecember
4.69%
4.60%
NVS
PG

Financials

NVS vs. PG - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab